AGTR1 and Hypertension: Treatment with the angiotensin-converting enzyme inhibitor perindopril significantly reduced AT1-AA and improved left ventricular function and left ventricular remodelling, which further confirms that AT1-AA are one of the important factors in the pathogenesis of hypertension and HF [20].